Literature DB >> 15265659

ICOS is essential for the development of experimental autoimmune myasthenia gravis.

Benjamin G Scott1, Huan Yang, Erdem Tüzün, Chen Dong, Richard A Flavell, Premkumar Christadoss.   

Abstract

Lymphocyte costimulation via the inducible costimulatory molecule (ICOS) is required for effective humoral immunity development. Following immunization with Torpedo acetylcholine receptor (AChR), ICOS gene knockout (KO) mice were highly resistant to clinical experimental autoimmune myasthenia gravis (EAMG) development, had less serum AChR-specific immunoglobulins (Igs), and exhibited a diminutive germinal center (GC) reaction in secondary lymphoid tissues. Lymphocyte proliferation and both Th1 and Th2 differentiation in response to AChR and the AChR dominant alpha146-162 peptide were inhibited by the ICOS gene deficiency. ICOS-mediated lymphocyte costimulation is thus vital to the induction of T cell-mediated humoral immunity to AChR and the development of clinical EAMG.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15265659     DOI: 10.1016/j.jneuroim.2004.04.019

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

Review 1.  Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis.

Authors:  Jeffrey T Guptill; Madhu Soni; Matthew N Meriggioli
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

2.  Transcriptional repressor Blimp1 regulates follicular regulatory T-cell homeostasis and function.

Authors:  Guang Yang; Xiaosu Yang; Junmei Zhang; Guancheng Li; Dandan Zheng; Anjiao Peng; Jue Hu; Liqun Xu; Baifeng Yang; Huan Yang; Wenbin Zhou; Erdem Tuzun; Jing Li
Journal:  Immunology       Date:  2017-10-19       Impact factor: 7.397

3.  Inducible costimulator expression regulates the magnitude of Th2-mediated airway inflammation by regulating the number of Th2 cells.

Authors:  Bryan S Clay; Rebecca A Shilling; Hozefa S Bandukwala; Tamson V Moore; Judy L Cannon; Andrew A Welcher; Joel V Weinstock; Anne I Sperling
Journal:  PLoS One       Date:  2009-11-04       Impact factor: 3.240

Review 4.  Follicular helper T cell in immunity and autoimmunity.

Authors:  D Mesquita; W M Cruvinel; L S Resende; F V Mesquita; N P Silva; N O S Câmara; L E C Andrade
Journal:  Braz J Med Biol Res       Date:  2016-04-19       Impact factor: 2.590

5.  Immune Skew of Circulating Follicular Helper T Cells Associates With Myasthenia Gravis Severity.

Authors:  Shinji Ashida; Hirofumi Ochi; Mio Hamatani; Chihiro Fujii; Kimitoshi Kimura; Yoichiro Okada; Yuichiro Hashi; Kazuyuki Kawamura; Hideki Ueno; Ryosuke Takahashi; Toshiki Mizuno; Takayuki Kondo
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-01-12

6.  B-cell-activating factor and autoimmune myasthenia gravis.

Authors:  Samia Ragheb; Robert P Lisak
Journal:  Autoimmune Dis       Date:  2011-11-28

7.  Improved methodology to obtain large quantities of correctly folded recombinant N-terminal extracellular domain of the human muscle acetylcholine receptor for inducing experimental autoimmune myasthenia gravis in rats.

Authors:  Chenjing Sun; Hongliang Zhang; Jiang Xu; Jie Gao; Xiaokun Qi; Zhuyi Li
Journal:  Arch Med Sci       Date:  2013-08-12       Impact factor: 3.318

8.  Attenuation of immune-mediated influenza pneumonia by targeting the inducible co-stimulator (ICOS) molecule on T cells.

Authors:  Priya Sakthivel; Marcus Gereke; Angele Breithaupt; Dietmar Fuchs; Luca Gigliotti; Achim D Gruber; Umberto Dianzani; Dunja Bruder
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.